How big is the bioprocess analyzers market?

In 2023, the global market was valued at approximately USD 2 billion. It is projected to grow at a CAGR of 11.5% from 2024 to 2032.

Why is the use of consumables & accessories rising in the bioprocess analyzers industry?

The consumables & accessories segment led the market with a revenue of USD 1.1 billion in 2023 and is expected to grow at a CAGR of 11% over the forecast period. The rise of automation and continuous bioprocessing drives demand for analyzer-compatible consumables.

How much is the North America bioprocess analyzers market worth?

The North American market is forecasted to reach USD 2 billion by 2032. In 2023, the U.S. dominated the market with a revenue of USD 712.7 million.

Who are some of the prominent players in the bioprocess analyzers industry?

Key players include 4BioCell GmbH & Co. KG, Agilent Technologies, Inc., Danaher Corporation, Endress+Hauser Group Services AG, Eppendorf AG, F. Hoffmann-La Roche Ltd., Nova Biomedical, and Randox Laboratories Ltd.

Bioprocess Analyzers Market Share

Report ID: GMI8765

Published Date: October 2024

Report Format: PDF

Download Free PDF

Bioprocess Analyzers Market Share

The market is highly competitive, featuring a mix of major global players and smaller to medium-sized companies vying for market share. A key aspect of market strategy involves the continuous introduction of innovations, such as advanced sensing technologies and integrated automation solutions. Notably, prominent industry players exert considerable influence in this dynamic landscape, often driving advancements through substantial investments in research and development.

Additionally, strategic alliances, acquisitions, and mergers play crucial roles in strengthening market positions and expanding global footprints amidst evolving regulatory landscapes, while a focus on sustainability and efficiency in bioprocessing further shapes the competitive landscape.

Bioprocess Analyzers Market Companies

Some of the eminent market participants operating in the Bioprocess Analyzers industry include:

4BioCell GmbH & Co. KG
Agilent Technologies, Inc.
Danaher Corporation
Endress+Hauser Group Services AG
Eppendorf AG
F. Hoffmann-La Roche Ltd.
Nova Biomedical
Randox Laboratories Ltd.
Sartorius AG
Solida Biotech GmBH
SYSBIOTECH GmbH
Thermo Fisher Scientific Inc.
Xylem Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Question(FAQ) :

How big is the bioprocess analyzers market?: In 2023, the global market was valued at approximately USD 2 billion. It is projected to grow at a CAGR of 11.5% from 2024 to 2032.
Why is the use of consumables & accessories rising in the bioprocess analyzers industry?: The consumables & accessories segment led the market with a revenue of USD 1.1 billion in 2023 and is expected to grow at a CAGR of 11% over the forecast period. The rise of automation and continuous bioprocessing drives demand for analyzer-compatible consumables.
How much is the North America bioprocess analyzers market worth?: The North American market is forecasted to reach USD 2 billion by 2032. In 2023, the U.S. dominated the market with a revenue of USD 712.7 million.
Who are some of the prominent players in the bioprocess analyzers industry?: Key players include 4BioCell GmbH & Co. KG, Agilent Technologies, Inc., Danaher Corporation, Endress+Hauser Group Services AG, Eppendorf AG, F. Hoffmann-La Roche Ltd., Nova Biomedical, and Randox Laboratories Ltd.

Related Reports

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Immediate Delivery

Single User: $4,123 $4,850

15% off

Multi User: $4,840 $6,050

20% off

Enterprise User: $5,845 $8,350

30% off

Buy now

Premium Report Details

Base Year: 2023

Companies covered: 13

Tables & Figures: 32

Countries covered: 22

Pages: 132

Download Free PDF

Bioprocess Analyzers Market Share

Bioprocess Analyzers Market Share

Bioprocess Analyzers Market Companies

Premium Report Details

Industries

Information

Link

Global Headquarters